JOHNSON & JOHNSON is 345.8x more valuable than Innoviva, Inc. by market capitalization ($573.71 B vs $1.66 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INVA | JNJ |
|---|---|---|
| Market cap | $1.66 B | $573.71 B |
| US-listed rank | #2257 | #20 |
| Revenue (latest FY) | $411.33M | $94.19B |
| Net income (latest FY) | - | $26.80B |
| Net margin | - | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 1,653 | 984 |
JOHNSON & JOHNSON is 345.8x more valuable than Innoviva, Inc. by market capitalization ($573.71 B vs $1.66 B).
In their latest fiscal years, Innoviva, Inc. reported $411.33M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Innoviva, Inc. and JOHNSON & JOHNSON, or browse the full rankings.